The University of Padua is an Italian university located in the city of Padua, region of Veneto, northern Italy. The University of Padua was founded in 1222 by a group of students and teachers from Bologna. Padua is the second-oldest university in Italy and the world's fifth-oldest surviving university.

During the past decade, University of Padova conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 17 clinical trials were completed, i.e. on average, 41.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Padova" #1 sponsor was "University of Padova" with 18 trials, followed by "Celgene" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "University of Virginia" with 4 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Padova" #1 collaborator was "University of Padova" with 7 trials as a collaborator, "A.O. Ospedale Papa Giovanni XXIII" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "University Hospital, Montpellier" with 2 trials as a collaborator and "University of Florence" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "University of Padova" are "Diabetes Mellitus, Type 1" (5 trials), "Type 1 Diabetes" (4 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "Atrial Fibrillation" (2 trials) and "Brain and Central Nervous System Tumors" (2 trials). Many other conditions were trialed in "University of Padova" in a lesser frequency.

Most popular intervention types in "University of Padova" are "Drug" (39 trials), "Device" (30 trials), "Other" (12 trials), "Procedure" (12 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Nintedanib" (3 trials), "conventional surgery" (3 trials), "fluorouracil" (3 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Padova" are 86 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Padova". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 60 completed trials in University of Padova, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Padova, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".

University of Padova has several departments that took part in Clinical trials: "Università degli Studi di Padova - Ematologia ed Immunologia Clinica" - 23 trials, "Department of Medicine - DIMED, University of Padova, Italy" - 8 trials, "Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua" - 4 trials, "Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari-Università di Padova" - 2 trials, "Università Degli Studi di Padova - Dipartimento di Pediatria - Servizio di Cardiologia Pediatrica - Site 1501" - 2 trials, "Neonatal Intensive Care Unit - University Hospital of Padua" - 2 trials, "Az. Osp. Di Padova; Dipart. Scienze Chirurgiche E Gastroent." - 2 trials